TY - JOUR T1 - Impact of the accuracy of case-based surveillance data on the estimation of time-varying reproduction numbers JF - medRxiv DO - 10.1101/2020.06.26.20140871 SP - 2020.06.26.20140871 AU - Michele Starnini AU - Alberto Aleta AU - Michele Tizzoni AU - Yamir Moreno Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/28/2020.06.26.20140871.abstract N2 - Studies aimed at characterizing the evolution of COVID-19 disease often rely on case-based surveillance data publicly released by health authorities, that can be incomplete and prone to errors. Here, we quantify the biases caused by the use of inaccurate data in the estimation of the Time-Varying Reproduction Number R(t). By focusing on Italy and Spain, two of the hardest-hit countries in Europe and worldwide, we show that if the symptoms’ onset time-series is inferred from the notification date series, the R(t) curve cannot capture nor describe accurately the early dynamics of the epidemic. Furthermore, the effectiveness of the containment measures that were implemented, such as national lockdowns, can be properly evaluated only when R(t) is estimated using the real time-series of dates of symptoms’ onset. Our findings show that extreme care should be taken when a pivotal quantity like R(t) is used to make decisions and to evaluate different alternatives.Competing Interest StatementMT reports consulting fees from GSK outside of the submitted work. The authors declare no other conflict of interest.Funding StatementAA and YM acknowledge partial support from Intesa Sanpaolo Innovation Center. MT acknowledges partial support by the European Union Horizon 2020 research and innovation programme - project EpiPose (No 101003688) and by the Lagrange Project funded by Fondazione CRT. YM acknowledges partial support from the Government of Aragon and FEDER funds, Spain through grant E36-20R (FENOL), and by MINECO and FEDER funds (FIS2017-87519-P). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:ISI Research Area CoordinatorAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used is publicly available ER -